US Edition4 Articles
4 Articles
The pharmaceutical laboratory disengages from sites that produce drugs that lose speed in the image of Lovenox, an anticoagulant.
The pharmaceutical laboratory plans to divest its industrial site installed in Val-de-Marne, while keeping the property of the anticoagulant, in loss of speed. Nine establishments of the group will have been transferred in one and a half years in France, according to the count of the unions.
The transfer was announced Monday to the trade unions. According to the press, the buyer is a German company. Local elected officials are worried about the 600 jobs.
The pharmaceutical giant has to formalize the sale of its Maisons-Alfort plant (Val-de-Marne) on Tuesday, July 1, 2025.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
